Analysis of metronidazole, clarithromycin and tetracycline resistance of Helicobacter pylori isolates from Korea
- Authors
- Kim, JJ; Reddy, R; Lee, M; Kim, JG; El-Zaatari, FAK; Osato, MS; Graham, DY; Kwon, DH
- Issue Date
- Apr-2001
- Publisher
- OXFORD UNIV PRESS
- Citation
- JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, v.47, no.4, pp 459 - 461
- Pages
- 3
- Indexed
- SCIE
SCOPUS
- Journal Title
- JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Volume
- 47
- Number
- 4
- Start Page
- 459
- End Page
- 461
- URI
- https://scholarworks.korea.ac.kr/kumedicine/handle/2020.sw.kumedicine/37304
- DOI
- 10.1093/jac/47.4.459
- ISSN
- 0305-7453
1460-2091
- Abstract
- Antibiotic resistance in Helicobacter pylori varies according to geographical region. We studied the primary resistance rates among 652 H. pylori isolated from Korea in relation to collection date, disease presentation, age and gender. Resistance rates were 40.6% (metronidazole), 5.9% (clarithromycin), 5.3% (tetracycline), 0% (amoxycillin), 1.5% (furazolidone) and 1.5% (nitrofurantoin). Resistance to metronidazole and clarithromycin increased from 1994 to 1999 (from 33.3 to 47.7% and 4.8 to 7.7%, respectively), but the differences only reached significance when rates of metronidazole resistance in women were compared with those in men (48.6 versus 36.9%).
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - 2. Clinical Science > Department of Internal Medicine > 1. Journal Articles
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.